MLTX MoonLake Immunotherapeutics

Watchlist

43.210
-0.390-0.89%

Close Feb 14 16:00 ET

43.210
0.0000.00%

Post 16:20 ET

2.72BMarket Cap-34.02P/E (TTM)

About MoonLake Immunotherapeutics Company

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

Company Profile

SymbolMLTX

Company NameMoonLake Immunotherapeutics

Listing DateOct 20, 2020

Founded2021

CEODr. Jorge Santos da Silva

MarketNASDAQ

Employees50

Fiscal Year Ends12-31

AddressDorfstrasse 29

CityZug

ProvinceZug

CountrySwitzerland

Zip Code6300

Phone41-510-80-22

Websitehttp://www.moonlaketx.com

Company Executives

Name
Position
Salary

Dr. Jorge Santos da Silva
Chief Executive Officer and Director
1.20M

Matthias Bodenstedt
Chief Financial Officer and Principal Accounting Officer
891.60K

Dr. Kristian Reich
Chief Scientific Officer
1.23M

Simon John Sturge
Chairman of the Board
315.49K

Dr. Ramnik Xavier
Independent Director
299.99K

Dr. Andrew Phillips, PhD
Independent Director
280.99K

Spike Loy
Independent Director
277.49K

Catherine Moukheibir
Independent Director
287.49K

MLTX MoonLake Immunotherapeutics

About MoonLake Immunotherapeutics Company

Company Profile

Company Executives

Trending Stocks